Drug profile · INN
telotristat etiprate
XERMELO
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
telotristat etiprate (XERMELO) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN telotristat etiprate
Brand XERMELO
Route ORAL
Formulation TABLET
Frequently asked questions
What is telotristat etiprate?
telotristat etiprate (XERMELO) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for telotristat etiprate?
XERMELO is a marketed brand name for telotristat etiprate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of telotristat etiprate?
telotristat etiprate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.